{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:01:44Z","timestamp":1791406904891,"version":"4.3.3"},"reference-count":158,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.pharmthera.2012.07.009","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T11:23:38Z","timestamp":1342783418000},"page":"216-226","source":"Crossref","is-referenced-by-count":313,"title":["Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis"],"prefix":"10.1016","volume":"136","author":[{"given":"Zuzana","family":"Saidak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre J.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.07.009_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00296-010-1687-8","article-title":"Possible benefits of strontium ranelate in complicated long bone fractures","volume":"32","author":"Alegre","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bone.2006.07.028","article-title":"Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women","volume":"40","author":"Alexandersen","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0015","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1172\/JCI35711","article-title":"NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism","volume":"118","author":"Aliprantis","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1359\/jbmr.070607","article-title":"Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength","volume":"22","author":"Ammann","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1359\/jbmr.071012","article-title":"Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate","volume":"23","author":"Arlot","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00198-008-0728-6","article-title":"Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response","volume":"20","author":"Atkins","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00198-008-0815-8","article-title":"Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants","volume":"20","author":"Bain","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.metabol.2003.10.022","article-title":"Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells","volume":"53","author":"Barbara","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0065","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0070-2153(06)76004-5","article-title":"Wnt signaling: a key regulator of bone mass","volume":"76","author":"Baron","year":"2006","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(02)02040-X","article-title":"In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation","volume":"450","author":"Baron","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0070","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.0408742102","article-title":"Regulation of osteoblastogenesis and bone mass by Wnt10b","volume":"102","author":"Bennett","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v9.i2.30","article-title":"Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology","volume":"9","author":"Bianco","year":"1999","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0080","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1074\/jbc.M109.054338","article-title":"Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes","volume":"285","author":"Bilkovski","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jocd.2006.10.004","article-title":"Effect of bone strontium on BMD measurements","volume":"10","author":"Blake","year":"2007","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0090","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0095","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s10856-011-4379-3","article-title":"Osteopenic bone cell response to strontium-substituted hydroxyapatite","volume":"22","author":"Boanini","year":"2011","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11154-006-9002-4","article-title":"Wnt signaling and osteoblastogenesis","volume":"7","author":"Bodine","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0105","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jbmr.5650110915","article-title":"Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration","volume":"11","author":"Boivin","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bone.2007.08.043","article-title":"Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro","volume":"42","author":"Bonnelye","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0120","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.actbio.2011.02.013","article-title":"A new insight into the dissociating effect of strontium on bone resorption and formation","volume":"7","author":"Braux","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0125","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1476-5381.2009.00305.x","article-title":"Osteoblasts play key roles in the mechanisms of action of strontium ranelate","volume":"157","author":"Brennan","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","article-title":"Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers","volume":"71","author":"Brown","year":"1991","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0145","first-page":"412","article-title":"Calcium-sensing receptors in bone cells","volume":"4","author":"Brown","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(08)60933-4","article-title":"G-protein-coupled, extracellular Ca(2+)-sensing receptor: a versatile regulator of diverse cellular functions","volume":"55","author":"Brown","year":"1999","journal-title":"Vitam Horm"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00223-010-9439-z","article-title":"Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures","volume":"88","author":"Bruel","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0165","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00198-009-1078-8","article-title":"Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3years","volume":"21","author":"Bruyere","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2007.075572","article-title":"Effects of strontium ranelate on spinal osteoarthritis progression","volume":"67","author":"Bruyere","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0155","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1210\/jc.2006-2758","article-title":"Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate","volume":"92","author":"Bruyere","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0170","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1016\/j.actbio.2010.07.019","article-title":"Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: matrix incorporation of strontium is accompanied by changes in mineralization and microstructure","volume":"6","author":"Busse","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/8756-3282(96)00080-4","article-title":"The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro","volume":"18","author":"Canalis","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0180","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jbm.a.31975","article-title":"Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells","volume":"89","author":"Capuccini","year":"2009","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0185","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1210\/jc.2011-0593","article-title":"Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide","volume":"96","author":"Carvalho","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/mol.109.063347","article-title":"Strontium ranelate decreases RANKL-induced osteoclastic differentiation in vitro: involvement of the calcium sensing receptor","volume":"78","author":"Caudrillier","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0195","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.bone.2008.02.010","article-title":"Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms","volume":"42","author":"Caverzasio","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000327950","article-title":"Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth","volume":"27","author":"Caverzasio","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0205","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jbspin.2007.01.034","article-title":"Effect of strontium ranelate on fracture healing in rat tibia","volume":"74","author":"Cebesoy","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0210","doi-asserted-by":"crossref","first-page":"ra1","DOI":"10.1126\/scisignal.1159945","article-title":"The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development","volume":"1","author":"Chang","year":"2008","journal-title":"Sci Signal"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0220","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bcp.2007.04.020","article-title":"The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation","volume":"74","author":"Chattopadhyay","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0215","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1210\/en.2003-1127","article-title":"Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts","volume":"145","author":"Chattopadhyay","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0225","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1359\/jbmr.070321","article-title":"Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins","volume":"22","author":"Choudhary","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0230","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.bone.2006.09.008","article-title":"Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure","volume":"40","author":"Compston","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0235","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pharmthera.2010.04.007","article-title":"Broad-spectrum amino acid-sensing class C G-protein coupled receptors: molecular mechanisms, physiological significance and options for drug development","volume":"127","author":"Conigrave","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1185\/03007995.2011.648758","article-title":"Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial","volume":"28","author":"Cooper","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","article-title":"Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis","volume":"7","author":"Costa","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0250","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0255","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0260","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S8756-3282(01)00419-7","article-title":"Incorporation and distribution of strontium in bone","volume":"28","author":"Dahl","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0265","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/jbmr.520","article-title":"Osteoblast extracellular Ca2+\u2010sensing receptor regulates bone development, mineralization, and turnover","volume":"26","author":"Dvorak-Ewell","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0270","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/jc.2010-2855","article-title":"The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density","volume":"96","author":"Fitzpatrick","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0275","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bone.2011.07.038","article-title":"Reduction by strontium of the bone marrow adiposity in mice and repression of the adipogenic commitment of multipotent C3H10T1\/2 cells","volume":"50","author":"Fournier","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0285","doi-asserted-by":"crossref","first-page":"25251","DOI":"10.1074\/jbc.M110.110502","article-title":"Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate","volume":"285","author":"Fromigu\u00e9","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0280","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1582-4934.2008.00673.x","article-title":"Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate","volume":"13","author":"Fromigu\u00e9","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0290","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00198-008-0602-6","article-title":"Strontium ranelate does not stimulate bone formation in ovariectomized rats","volume":"19","author":"Fuchs","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0295","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1210\/en.142.9.3996","article-title":"Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype","volume":"142","author":"Garner","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0300","doi-asserted-by":"crossref","first-page":"33132","DOI":"10.1074\/jbc.M500608200","article-title":"Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression","volume":"280","author":"Gaur","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0305","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.biomaterials.2010.01.121","article-title":"The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro","volume":"31","author":"Gentleman","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0310","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-007-0515-9","article-title":"Influence of osteoporosis on fracture fixation\u2014a systematic literature review","volume":"19","author":"Goldhahn","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0315","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","article-title":"Inflammation in osteoarthritis","volume":"23","author":"Goldring","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0325","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00223-009-9317-8","article-title":"Strontium ranelate enhances callus strength more than PTH 1\u201334 in an osteoporotic rat model of fracture healing","volume":"86","author":"Habermann","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0330","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1166\/jnn.2012.5125","article-title":"Evaluation of osteoinduction and proliferation on nano-Sr-HAP: a novel orthopedic biomaterial for bone tissue regeneration","volume":"12","author":"Hao","year":"2012","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1359\/jbmr.2001.16.2.299","article-title":"Strontium ranelate increases cartilage matrix formation","volume":"16","author":"Henrotin","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0345","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S8756-3282(03)00115-7","article-title":"S12911-2 reduces bone loss induced by short-term immobilization in rats","volume":"33","author":"Hott","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0350","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1074\/jbc.M801668200","article-title":"The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways","volume":"284","author":"Hurtel-Lemaire","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0355","doi-asserted-by":"crossref","first-page":"130","DOI":"10.22203\/eCM.v021a11","article-title":"Effects of strontium-doped bioactive glass on the differentiation of cultured osteogenic cells","volume":"21","author":"Isaac","year":"2011","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0360","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0365","doi-asserted-by":"crossref","first-page":"e23638","DOI":"10.1371\/journal.pone.0023638","article-title":"Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment","volume":"6","author":"Jobke","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0370","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2011.04.007","article-title":"ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans","volume":"49","author":"John","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0375","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/bbrc.1998.8448","article-title":"Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells","volume":"245","author":"Kameda","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0380","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.0932","article-title":"High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells","volume":"261","author":"Kanatani","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1474-9726.2011.00669.x","article-title":"Senescence-associated intrinsic mechanisms of osteoblast dysfunctions","volume":"10","author":"Kassem","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0390","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ecl.2005.07.009","article-title":"Pathophysiology of age-related bone loss and osteoporosis","volume":"34","author":"Khosla","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0395","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","article-title":"NFAT and Osterix cooperatively regulate bone formation","volume":"11","author":"Koga","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0400","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1172\/JCI17416","article-title":"The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone","volume":"111","author":"Kos","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0405","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","article-title":"An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation","volume":"46","author":"Kumar","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0430","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbrc.2012.01.088","article-title":"Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells","volume":"418","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0425","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00198-009-1140-6","article-title":"Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats","volume":"21","author":"Li","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0420","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0410","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1359\/jbmr.091038","article-title":"Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment","volume":"25","author":"Li","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0415","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0435","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.bone.2010.01.379","article-title":"Strontium ranelate improves implant osseointegration","volume":"46","author":"Maimoun","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0445","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0440","doi-asserted-by":"crossref","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","author":"Manolagas","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0450","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00198-008-0740-x","article-title":"Effective doses for strontium ranelate","volume":"19","author":"Marie","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0455","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bone.2009.07.082","article-title":"The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis","volume":"46","author":"Marie","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0460","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/mi.10.5.7","article-title":"Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology","volume":"10","author":"Marie","year":"2010","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0480","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-010-1369-0","article-title":"How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis","volume":"22","author":"Marie","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0465","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.5650080512","article-title":"An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats","volume":"8","author":"Marie","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0470","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1210\/jc.2010-2113","article-title":"Extrinsic mechanisms involved in age-related defective bone formation","volume":"96","author":"Marie","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-11-0132","article-title":"Osteoblasts In osteoporosis: past, emerging and future anabolic targets","volume":"165","author":"Marie","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/08977194.2012.656761","article-title":"FGF\/FGFR signaling in bone formation: Progress and perspectives","volume":"30","author":"Marie","year":"2012","journal-title":"Growth Factors"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0490","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2008.07.006","article-title":"Bone remodelling: its local regulation and the emergence of bone fragility","volume":"22","author":"Martin","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0495","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.1475","article-title":"Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys","volume":"27","author":"Masarachia","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0500","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1096\/fj.06-6304fje","article-title":"The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis","volume":"20","author":"Mentaverri","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0505","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0510","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0515","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2174\/1381612023393387","article-title":"Pharmacological regulation of parathyroid hormone secretion","volume":"8","author":"Nemeth","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0520","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10856-011-4264-0","article-title":"The effect of strontium incorporation in hydroxyapatite on osteoblasts in vitro","volume":"22","author":"Ni","year":"2011","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0525","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1172\/JCI42528","article-title":"Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation","volume":"120","author":"Nishikawa","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0530","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.cr.7290260","article-title":"Wnt signaling in disease and in development","volume":"15","author":"Nusse","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0535","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0540","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jor.21204","article-title":"Effect of strontium ranelate on fracture healing in the osteoporotic rats","volume":"29","author":"Ozturan","year":"2011","journal-title":"J Orthop Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0545","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.1500","article-title":"Role of T cells in ovariectomy induced bone loss\u2014revisited","volume":"27","author":"Pacifici","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0550","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1098\/rsif.2009.0504","article-title":"Strontium borate glass: potential biomaterial for bone regeneration","volume":"7","author":"Pan","year":"2010","journal-title":"J R Soc Interface"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2012.07.009_bb0555","doi-asserted-by":"crossref","first-page":"i119","DOI":"10.1136\/ard.2010.141150","article-title":"Targeting sclerostin as potential treatment of osteoporosis","volume":"70","author":"Papapoulos","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0570","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bone.2011.08.031","article-title":"The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin","volume":"49","author":"Peng","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0565","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/jor.21127","article-title":"In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells","volume":"28","author":"Peng","year":"2010","journal-title":"J Orthop Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0585","doi-asserted-by":"crossref","first-page":"e3858","DOI":"10.1371\/journal.pone.0003858","article-title":"GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome","volume":"3","author":"Pi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0580","doi-asserted-by":"crossref","first-page":"40201","DOI":"10.1074\/jbc.M505186200","article-title":"Identification of a novel extracellular cation-sensing G-protein-coupled receptor","volume":"280","author":"Pi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0575","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1359\/jbmr.040114","article-title":"A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium","volume":"19","author":"Pi","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0590","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1359\/jbmr.091037","article-title":"Impaired osteoblast function in GPRC6A null mice","volume":"25","author":"Pi","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0595","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0163-7258(03)00038-X","article-title":"Evolution, structure, and activation mechanism of family 3\/C G-protein-coupled receptors","volume":"98","author":"Pin","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0600","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0605","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.090315","article-title":"Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis","volume":"24","author":"Recker","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.07.009_bb0615","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bone.2011.12.024","article-title":"Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women","volume":"50","author":"Reginster","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0620","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00198-011-1847-z","article-title":"Maintenance of antifracture efficacy over 10years with strontium ranelate in postmenopausal osteoporosis","volume":"23","author":"Reginster","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0610","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0625","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1359\/JBMR.041114","article-title":"Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling","volume":"20","author":"Riggs","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0630","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00198-011-1758-z","article-title":"Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study","volume":"23","author":"Rizzoli","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0635","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1359\/jbmr.091028","article-title":"Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3years of strontium ranelate treatment","volume":"25","author":"Roschger","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0640","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.060101","article-title":"Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors","volume":"21","author":"Roux","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0645","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0650","doi-asserted-by":"crossref","first-page":"23771","DOI":"10.1074\/jbc.M111.251116","article-title":"An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts","volume":"286","author":"Rybchyn","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0660","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/mol.109.058784","article-title":"Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications","volume":"76","author":"Saidak","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0665","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1474-9726.2012.00804.x","article-title":"Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc\/Maf and Wnt signaling","volume":"11","author":"Saidak","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0655","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1210\/er.2008-0041","article-title":"The role of the calcium-sensing receptor in the development and progression of cancer","volume":"30","author":"Saidak","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0670","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0675","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semnephrol.2003.08.012","article-title":"Bone disease after kidney transplantation","volume":"24","author":"Sprague","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0680","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","article-title":"Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis","volume":"5","author":"Takada","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0685","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1359\/jbmr.2003.18.6.1082","article-title":"S 12911\u20132 inhibits osteoclastic bone resorption in vitro","volume":"18","author":"Takahashi","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.07.009_bb0690","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-0030-1255091","article-title":"The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization","volume":"42","author":"Takaoka","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0695","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0700","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1182\/blood-2004-10-4074","article-title":"Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice","volume":"106","author":"Tanaka","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0705","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bone.2011.06.005","article-title":"Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts","volume":"49","author":"Tat","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0710","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI200317054","article-title":"Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background","volume":"111","author":"Tu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0715","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/en.141.9.3478","article-title":"Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function","volume":"141","author":"Udagawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0720","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00296-010-1733-6","article-title":"The expression of RANKL and OPG in the various grades of osteoarthritic cartilage","volume":"32","author":"Upton","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0725","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0730","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/17453674.2011.618909","article-title":"Strontium doping of bone graft extender","volume":"82","author":"Vestermark","year":"2011","journal-title":"Acta Orthop"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0735","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1677\/JME-08-0149","article-title":"No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions","volume":"42","author":"Wellendorph","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0740","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","article-title":"Calcineurin\/NFAT signaling in osteoblasts regulates bone mass","volume":"10","author":"Winslow","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0745","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jbm.a.20089","article-title":"In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (sr-HA) bioactive cement","volume":"68","author":"Wong","year":"2004","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0750","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1016\/j.biomaterials.2009.04.016","article-title":"Mechanical properties and in vitro response of strontium-containing hydroxyapatite\/polyetheretherketone composites","volume":"30","author":"Wong","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0755","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jbm.a.30815","article-title":"Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics","volume":"79","author":"Xue","year":"2006","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0760","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/en.139.8.3561","article-title":"Extracellular calcium (Ca2+(o))-sensing receptor in a murine bone marrow-derived stromal cell line (ST2): potential mediator of the actions of Ca2+(o) on the function of ST2 cells","volume":"139","author":"Yamaguchi","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0765","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1359\/jbmr.1998.13.10.1530","article-title":"Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells","volume":"13","author":"Yamaguchi","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0770","doi-asserted-by":"crossref","first-page":"C382","DOI":"10.1152\/ajpcell.2001.280.2.C382","article-title":"Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line","volume":"280","author":"Yamaguchi","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0775","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0780","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jcp.1041490310","article-title":"Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a \u201ccalcium receptor\u201d","volume":"149","author":"Zaidi","year":"1991","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0785","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.actbio.2010.08.031","article-title":"Effects of strontium in modified biomaterials","volume":"7","author":"Zhang","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.pharmthera.2012.07.009_bb0790","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2007.01.120","article-title":"Induction of a program gene expression during osteoblast differentiation with strontium ranelate","volume":"355","author":"Zhu","year":"2007","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:02:13Z","timestamp":1714194133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":158,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0163725812001349"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.009","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}